Breakpoints characterisation of the genomic deletions identified by MLPA in alkaptonuria patients.

Andrea Soltysova, Martina Sekelska, Andrea Zatkova

European journal of human genetics : EJHG 2023 Apr

filter terms:

Until recently, mainly DNA sequencing has been used to identify variants within the gene coding for homogentisate dioxygenase (HGD, 3q13.33) that cause alkaptonuria (AKU), an autosomal recessive inborn error of metabolism of tyrosine. In order to identify possible larger genomic deletions we have developed a novel Multiplex Ligation-dependent Probe Amplification (MLPA) assay specific for this gene (HGD-MLPA) and tested it successfully in healthy controls and in patients carrying two known previously identified HGD deletions. Subsequently, we analysed 22 AKU patients in whom only one or none classical HGD variant was found by sequencing. Using HGD-MLPA and sequencing, we identified four larger deletions encompassing from 1 to 4 exons of this gene and we defined their exact breakpoints: deletion of exons 1-4 (c.1-8460_282 + 6727del), deletion of exons 5 and 6 (c.283-9199_434 + 1688del), deletion of exon 11 (c.775-1915_879 + 1293del), and deletion of exon 13 (c.1007-1709_1188 + 1121del). We suggest including MLPA in the DNA diagnostic protocols for AKU in cases where DNA sequencing does not lead to identification of both HGD variants. © 2022. The Author(s), under exclusive licence to European Society of Human Genetics.

Citation

Andrea Soltysova, Martina Sekelska, Andrea Zatkova. Breakpoints characterisation of the genomic deletions identified by MLPA in alkaptonuria patients. European journal of human genetics : EJHG. 2023 Apr;31(4):485-489